InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the complete record of transactions filed by Duncan Jason, Directeur Juridique. Officer active across 1 companies, notably Albireo Pharma, INC.. Aggregated, 11 disclosures have been published. Total volume traded: €36k. The latest transaction was filed on 22 April 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
€7,325240 shares@ €30.5211.8% of flow
Common Stock
SEC:0001209191-22-025522:0·
€9,127416 shares@ €21.93912.3% of flow
Common Stock
SEC:0001209191-22-004809:0·
€9,127416 shares@ €21.93914.6% of flow
Common Stock
SEC:0001209191-22-004809·
010,800 shares0
Common Stock
SEC:0001209191-22-004060:0·
010,800 shares0
Common Stock
SEC:0001209191-22-004060·
€2,35895 shares@ €24.81721.2% of flow
Common Stock
SEC:0001209191-21-061556·
€2,35895 shares@ €24.81720.6% of flow
Common Stock
SEC:0001209191-21-061556:0·
€2,60990 shares@ €28.99071.3% of flow
Common Stock
SEC:0001209191-21-048160·
€2,60990 shares@ €28.99070.6% of flow
Common Stock
SEC:0001209191-21-048160:0·
€184,1149,137 shares@ €20.150392.9% of flow
Common Stock
SEC:0001209191-21-043467·
€184,1149,137 shares@ €20.150345.6% of flow
Common Stock
SEC:0001209191-21-043467:0·
11 of 11 declarations
About Duncan Jason
Jason Duncan is the Chief Legal Officer and General Counsel at Albireo Pharma, Inc. He is responsible for managing the company's legal affairs and regulatory compliance. With a strong background in business law, he plays a key role in protecting the company's interests while ensuring compliance with applicable laws.
